SEC Form 4/A · accession 0001705477-26-000002
Edgewise Therapeutics, Inc. · EWTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael Nofi
Officer — Chief Financial Officer
Period of report
Aug 12, 2026
Accepted (ET)
Aug 17, 2026 · 6:41 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001710072
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $43.56 | Aug 12, 2026 | A | 48,750 | A | — | Aug 12, 2036 | Common Stock | 48,750 | 48,750 | D |
Explanation of responses
- F11/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date.
Remarks
This amendment corrects the exercise price of the reported option grant, which was reported as $0.00 due to a clerical/administrative error. The correct exercise price is $43.56, which reflects the fair market value of the underlying security on the date of grant.